Use of peripheral blood transcriptome biomarkers for epilepsy prediction

Neuroscience Letters

Volumn 497, Issue 3, 2011, Pages 213-217

  Karsten, Stanislav L ^a,b,c   Kudo, Lili C ^c   Bragin, Anatol J ^b  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NeuroInDx Inc   (United States)

Author keywords

Epilepsy; Epileptogenesis; Gene expression; Microarrays; Peripheral blood; Status epilepticus.; Transcriptome

Indexed keywords

BIOLOGICAL MARKER; FREE RADICAL; TRANSCRIPTOME;

BLOOD; BLOOD BRAIN BARRIER; BRAIN; BRAIN DAMAGE; BRAIN ELECTROPHYSIOLOGY; BRAIN INJURY; CELL LOSS; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION PROFILING; GLIOSIS; HIGH FREQUENCY OSCILLATION; HUMAN; MICROARRAY ANALYSIS; NERVE CELL; NERVE FIBER; NERVE SPROUTING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRAIN; EPILEPSY; GENE EXPRESSION PROFILING; HUMANS; TRANSCRIPTOME;

EID: 79957864089     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.019     Document Type: Review

References (69)

1. Annegers J.F., Hauser W.A., Coan S.P., Rocca W.A. A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 1998, 338:20-24.
2. Babb T.L., Pereira-Leite J., Mathern G.W., Pretorius J.K. Kainic acid induced hippocampal seizures in rats: comparisons of acute and chronic seizures using intrahippocampal versus systemic injections. Ital. J. Neurol. Sci. 1995, 16:39-44.
3. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
4. Borovecki F., Lovrecic L., Zhou J., Jeong H., Then F., Rosas H.D., Hersch S.M., Hogarth P., Bouzou B., Jensen R.V., Krainc D. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11023-11028.
5. Bouilleret V., Nehlig A., Marescaux C., Namer I.J. Magnetic resonance imaging follow-up of progressive hippocampal changes in a mouse model of mesial temporal lobe epilepsy. Epilepsia 2000, 41:642-650.
6. Bragin A., Csicsvari J., Penttonen M., Buzsaki G. Epileptic afterdischarge in the hippocampal-entorhinal system: current source density and unit studies. Neuroscience 1997, 76:1187-1203.
7. Bragin A., Engel J., Wilson C.L., Fried I., Buzsaki G. High-frequency oscillations in human brain. Hippocampus 1999, 9:137-142.
8. Bragin A., Engel J., Wilson C.L., Fried I., Mathern G.W. Hippocampal and entorhinal cortex high-frequency oscillations (100-500Hz) in human epileptic brain and in kainic acid-treated rats with chronic seizures. Epilepsia 1999, 40:127-137.
9. Bragin A., Mody I., Wilson C.L., Engel J. Local generation of fast ripples in epileptic brain. J. Neurosci. 2002, 22:2012-2021.
10. Bragin A., Wilson C.L., Engel J. Spatial stability over time of brain areas generating fast ripples in the epileptic rat. Epilepsia 2003, 44:1233-1237.
11. Bragin A., Wilson C.L., Staba R.J., Reddick M., Fried I., Engel J. Interictal high-frequency oscillations (80-500Hz) in the human epileptic brain: entorhinal cortex. Ann. Neurol. 2002, 52:407-415.
12. Chio A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009, 10:310-323.
13. Coppola G., Karydas A., Rademakers R., Wang Q., Baker M., Hutton M., Miller B.L., Geschwind D.H. Gene expression study on peripheral blood identifies progranulin mutations. Ann. Neurol. 2008, 64:92-96.
14. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
15. de Curtis M., Avanzini G. Interictal spikes in focal epileptogenesis. Prog. Neurobiol. 2001, 63:541-567.
16. Dichter M.A. Posttraumatic epilepsy: the challenge of translating discoveries in the laboratory to pathways to a cure. Epilepsia 2009, 50(Suppl. 2):41-45.
17. Engel J. Classification of epileptic disorders. Epilepsia 2001, 42:316.
18. Engel J. Mesial temporal lobe epilepsy: what have we learned?. Neuroscientist 2001, 7:340-352.
19. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803.
20. Fabene P.F., Bramanti P., Constantin G. The emerging role for chemokines in epilepsy. J. Neuroimmunol. 2010.
21. Fabene P.F., Navarro Mora G., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 2008, 14:1377-1383.
22. Finch N., Baker M., Crook R., Swanson K., Kuntz K., Surtees R., Bisceglio G., Rovelet-Lecrux A., Boeve B., Petersen R.C., Dickson D.W., Younkin S.G., Deramecourt V., Crook J., Graff-Radford N.R., Rademakers R. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009, 132:583-591.
23. Gandhi K.S., McKay F.C., Cox M., Riveros C., Armstrong N., Heard R.N., Vucic S., Williams D.W., Stankovich J., Brown M., Danoy P., Stewart G.J., Broadley S., Moscato P., Lechner-Scott J., Scott R.J., Booth D.R. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum. Mol. Genet. 2010, 19:2134-2143.
24. Gregg J.P., Lit L., Baron C.A., Hertz-Picciotto I., Walker W., Davis R.A., Croen L.A., Ozonoff S., Hansen R., Pessah I.N., Sharp F.R. Gene expression changes in children with autism. Genomics 2008, 91:22-29.
25. Grunblatt E., Bartl J., Zehetmayer S., Ringel T.M., Bauer P., Riederer P., Jacob C.P. Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. J. Alzheimers Dis. 2009, 16:627-634.
26. Hauser W.A., Hesdorffer D.H. Epilepsy: Frequency, Causes and Consequences 1990, Demos Press, New York.
27. Hauser W.A., Rich S.S., Lee J.R., Annegers J.F., Anderson V.E. Risk of recurrent seizures after two unprovoked seizures [see comments]. N. Engl. J. Med. 1998, 338:429-434.
28. Hellier J.L., Patrylo P.R., Dou P., Nett M., Rose G.M., Dudek F.E. Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment. J. Neurosci. 1999, 19:10053-10064.
29. Hershey A.D., Tang Y., Powers S.W., Kabbouche M.A., Gilbert D.L., Glauser T.A., Sharp F.R. Genomic abnormalities in patients with migraine and chronic migraine: preliminary blood gene expression suggests platelet abnormalities. Headache 2004, 44:994-1004.
30. Hildebrandt M., Amann K., Schroder R., Pieper T., Kolodziejczyk D., Holthausen H., Buchfelder M., Stefan H., Blumcke I. White matter angiopathy is common in pediatric patients with intractable focal epilepsies. Epilepsia 2008, 49:804-815.
31. Iwamoto K., Kato T. Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist 2006, 12:349-361.
32. Jirsch J.D., Urrestarazu E., LeVan P., Olivier A., Dubeau F., Gotman J. High-frequency oscillations during human focal seizures. Brain 2006, 129:1593-1608.
33. Jupp B., Williams J.P., Tesiram Y.A., Vosmansky M., O'Brien T.J. Hippocampal T2 signal change during amygdala kindling epileptogenesis. Epilepsia 2006, 47:41-46.
34. Kairiss E.W., Racine R.J., Smith G.K. The development of the interictal spike during kindling in the rat. Brain Res. 1984, 322:101-110.
35. Kalman J., Kitajka K., Pakaski M., Zvara A., Juhasz A., Vincze G., Janka Z., Puskas L.G. Gene expression profile analysis of lymphocytes from Alzheimer's patients. Psychiatr. Genet. 2005, 15:1-6.
36. Karsten S., Vi N., Bragin A., Mazarati A., Kudo L. Peripheral blood transcriptome biomarkers for the prediction of epilepsy during early latent period. Epilepsia 2009, 50:391-392.
37. Karsten S., Vi N., Bragin A., Mazarati A., Kudo L. Predicting epilepsy with peripheral blood transcriptome biomarkers during early latent period. FASEB J. 2010, 24.
38. Karsten S.L., Kudo L.C., Geschwind D.H. Gene expression analysis of neural cells and tissues using DNA microarrays. Current Protocols in Neuroscience/Editorial Board 2008, (Jacqueline N. Crawley, et al., Chapter 4, Unit 4, 28).
39. Kato T., Ishiwata M., Mori K., Washizuka S., Tajima O., Akiyama T., Kato N. Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropsychopharmacol. 2003, 6:379-389.
40. Kim J.V., Kang S.S., Dustin M.L., McGavern D.B. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009, 457:191-195.
41. Kudo L.C., Parfenova L., Vi N., Lau K., Pomakian J., Valdmanis P., Rouleau G.A., Vinters H.V., Wiedau-Pazos M., Karsten S.L. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum. Mol. Genet. 2010.
42. Langendorf F., Pedley T.A., Temkin N. Posttraumatic seizures. Epilepsy: A Comprehensive Textbook 2008, vol. 3:2537-2542. Wolters Kluwer, Philadelhia.
43. Lincecum J.M., Vieira F.G., Wang M.Z., Thompson K., De Zutter G.S., Kidd J., Moreno A., Sanchez R., Carrion I.J., Levine B.A., Al-Nakhala B.M., Sullivan S.M., Gill A., Perrin S. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat. Genet. 2010, 42:392-399.
44. Lit L., Enstrom A., Sharp F.R., Gilbert D.L. Age-related gene expression in Tourette syndrome. J. Psychiatr. Res. 2009, 43:319-330.
45. Maas A.I., Stocchetti N., Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008, 7:728-741.
46. Maes O.C., Xu S., Yu B., Chertkow H.M., Wang E., Schipper H.M. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging 2006.
47. Mohr S., Liew C.C. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol. Med. 2007, 13:422-432.
48. Nagasaka Y., Dillner K., Ebise H., Teramoto R., Nakagawa H., Lilius L., Axelman K., Forsell C., Ito A., Winblad B., Kimura T., Graff C. A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14854-14859.
49. Petryshen T.L., Middleton F.A., Kirby A., Aldinger K.A., Purcell S., Tahl A.R., Morley C.P., McGann L., Gentile K.L., Rockwell G.N., Medeiros H.M., Carvalho C., Macedo A., Dourado A., Valente J., Ferreira C.P., Patterson N.J., Azevedo M.H., Daly M.J., Pato C.N., Pato M.T., Sklar P. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol. Psychiatry 2005, 10:366-374. 328.
50. Pianese L., Turano M., Lo Casale M.S., De Biase I., Giacchetti M., Monticelli A., Criscuolo C., Filla A., Cocozza S. Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers. J. Neurol. Neurosurg. Psychiatry 2004, 75:1061-1063.
51. Roch C., Leroy C., Nehlig A., Namer I.J. Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 2002, 43:325-335.
52. Rollins B., Martin M.V., Morgan L., Vawter M.P. Analysis of whole genome biomarker expression in blood and brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:919-936.
53. Saris C.G., Horvath S., van Vught P.W., van Es M.A., Blauw H.M., Fuller T.F., Langfelder P., DeYoung J., Wokke J.H., Veldink J.H., van den Berg L.H., Ophoff R.A. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genomics 2009, 10:405.
54. Scherzer C.R., Eklund A.C., Morse L.J., Liao Z., Locascio J.J., Fefer D., Schwarzschild M.A., Schlossmacher M.G., Hauser M.A., Vance J.M., Sudarsky L.R., Standaert D.G., Growdon J.H., Jensen R.V., Gullans S.R. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:955-960.
55. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol. Psychiatry 2005, 10:500-513. 425.
56. Sharp F.R., Lit L., Xu H., Apperson M., Walker W., Wong B., Gilbert D.L., Hershey A., Glauser T.A. Genomics of brain and blood: progress and pitfalls. Epilepsia 2006, 47:1603-1607.
57. Sharp F.R., Xu H., Lit L., Walker W., Apperson M., Gilbert D.L., Glauser T.A., Wong B., Hershey A., Liu D.Z., Pinter J., Zhan X., Liu X., Ran R. The future of genomic profiling of neurological diseases using blood. Arch. Neurol. 2006, 63:1529-1536.
58. Sharp F.R., Xu H., Lit L., Walker W., Pinter J., Apperson M., Verro P. Genomic profiles of stroke in blood. Stroke 2007, 38:691-693.
59. Staba R.J., Wilson C.L., Bragin A., Fried I., Engel J. Quantitative analysis of high-frequency oscillations (80-500Hz) recorded in human epileptic hippocampus and entorhinal cortex. J. Neurophysiol. 2002, 88:1743-1752.
60. Staley K.J., Dudek F.E. Interictal spikes and epileptogenesis. Epilepsy Curr. 2006, 6:199-202.
61. Tang Y., Gilbert D.L., Glauser T.A., Hershey A.D., Sharp F.R. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch. Neurol. 2005, 62:210-215.
62. Tang Y., Lu A., Aronow B.J., Sharp F.R. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann. Neurol. 2001, 50:699-707.
63. Temkin N.R Preventing and treating posttraumatic seizures: the human experience. Epilepsia 2009, 50(Suppl. 2):10-13.
64. Tian Y., Green P.G., Stamova B., Hertz-Picciotto I., Pessah I.N., Hansen R., Yang X., Gregg J.P., Ashwood P., Jickling G., Van de Water J., Sharp F.R. Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotoxicol. Res. 2009.
65. Turner M.R., Kiernan M.C., Leigh P.N., Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009, 8:94-109.
66. Vawter M.P., Ferran E., Galke B., Cooper K., Bunney W.E., Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr. Res. 2004, 67:41-52.
67. Vernon S.D., Whistler T., Aslakson E., Rajeevan M., Reeves W.C. Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics 2006, 7:211-218.
68. Worrell G.A., Parish L., Cranstoun S.D., Jonas R., Baltuch G., Litt B. High-frequency oscillations and seizure generation in neocortical epilepsy. Brain 2004, 127:1496-1506.
69. Zhan X., Ander B.P., Jickling G., Turner R., Stamova B., Xu H., Liu D., Davis R.R., Sharp F.R. Brief focal cerebral ischemia that simulates transient ischemic attacks in humans regulates gene expression in rat peripheral blood. J. Cereb. Blood Flow Metab. 2010, 30:110-118.